Average Co-Inventor Count = 4.46
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. The General Hospital Corporation (10 from 2,893 patents)
2. Alnylam Pharmaceuticals, Inc. (6 from 444 patents)
3. Ferrumax Corporation (2 from 2 patents)
4. Ferrumax Pharmaceuticals, Inc. (0 patent)
16 patents:
1. 10611820 - Nucleic acids encoding hemojuvelin fusion proteins and uses thereof
2. 10273273 - Compositions for regulating iron homeostasis and methods of using same
3. 9758567 - Hemojuvelin fusion proteins and uses thereof
4. 9708379 - Compositions for regulating iron homeostasis and methods of using same
5. 9556251 - Methods and compositions to regulate hepcidin expression
6. 9506067 - Compositions and methods for inhibiting expression of the HAMP gene
7. 9090895 - Compositions and methods for inhibiting expression of the HAMP gene
8. 8895002 - Hemojuvelin fusion proteins and uses thereof
9. 8865168 - Methods and compositions to regulate hepcidin expression
10. 8791250 - Compositions and methods for inhibiting expression of the HAMP gene
11. 8637023 - Hemojuvelin fusion proteins
12. 8470799 - Compositions and methods for inhibiting expression of the HAMP gene
13. 8293236 - Use of modulators of compounds of TGF-β superfamily to regulate hepcidin-mediated iron metabolism
14. 8268799 - Compositions and methods for inhibiting expression of the HAMP gene
15. 8163711 - Compositions and methods for inhibiting expression of the HAMP gene